RU2379289C2 - Соединение индолина и способ его получения - Google Patents

Соединение индолина и способ его получения Download PDF

Info

Publication number
RU2379289C2
RU2379289C2 RU2007115888/04A RU2007115888A RU2379289C2 RU 2379289 C2 RU2379289 C2 RU 2379289C2 RU 2007115888/04 A RU2007115888/04 A RU 2007115888/04A RU 2007115888 A RU2007115888 A RU 2007115888A RU 2379289 C2 RU2379289 C2 RU 2379289C2
Authority
RU
Russia
Prior art keywords
propyl
dihydro
ethyl
trifluoroethoxy
phenoxy
Prior art date
Application number
RU2007115888/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2007115888A (ru
Inventor
Тосиаки ЯМАГУТИ (JP)
Тосиаки ЯМАГУТИ
Икуо ЦУТИЯ (JP)
Икуо ЦУТИЯ
Кён КИКУТИ (JP)
Кён КИКУТИ
Такаси ЯНАГИ (JP)
Такаси ЯНАГИ
Original Assignee
Киссеи Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Киссеи Фармасьютикал Ко., Лтд. filed Critical Киссеи Фармасьютикал Ко., Лтд.
Publication of RU2007115888A publication Critical patent/RU2007115888A/ru
Application granted granted Critical
Publication of RU2379289C2 publication Critical patent/RU2379289C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2007115888/04A 2004-10-27 2005-10-24 Соединение индолина и способ его получения RU2379289C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004313040 2004-10-27
JP2004-313040 2004-10-27

Publications (2)

Publication Number Publication Date
RU2007115888A RU2007115888A (ru) 2008-11-10
RU2379289C2 true RU2379289C2 (ru) 2010-01-20

Family

ID=36227738

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007115888/04A RU2379289C2 (ru) 2004-10-27 2005-10-24 Соединение индолина и способ его получения

Country Status (17)

Country Link
US (1) US7834193B2 (cg-RX-API-DMAC7.html)
EP (1) EP1806340B1 (cg-RX-API-DMAC7.html)
JP (1) JP5049013B2 (cg-RX-API-DMAC7.html)
KR (1) KR101249865B1 (cg-RX-API-DMAC7.html)
CN (1) CN101048376B (cg-RX-API-DMAC7.html)
AT (1) ATE508113T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005298078B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0517515B8 (cg-RX-API-DMAC7.html)
CA (1) CA2583660C (cg-RX-API-DMAC7.html)
DE (1) DE602005027881D1 (cg-RX-API-DMAC7.html)
ES (1) ES2362788T3 (cg-RX-API-DMAC7.html)
IL (1) IL182642A (cg-RX-API-DMAC7.html)
MX (1) MX2007005126A (cg-RX-API-DMAC7.html)
RU (1) RU2379289C2 (cg-RX-API-DMAC7.html)
TW (1) TW200621709A (cg-RX-API-DMAC7.html)
WO (1) WO2006046499A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200703996B (cg-RX-API-DMAC7.html)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78854C2 (en) * 2002-09-06 2007-04-25 Kissei Pharmaceutical Crystal for an oral solid drug and oral solid drug for dysuria treatment containing the same
WO2008106125A2 (en) 2007-02-26 2008-09-04 Concert Pharmaceuticals, Inc. Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists
MX2009009230A (es) * 2007-02-28 2009-11-26 Kissei Pharmaceutical Uso de silodosina en una administracion diaria para tratar hiperplasia prostatica benigna.
CN101585798B (zh) * 2008-05-20 2011-06-15 浙江华海药业股份有限公司 光学活性化合物1-(3-苯甲酰氧基丙基)-5-(2-(1-苯基乙基胺)丙基)-7-氰基吲哚啉及其制备方法和用途
CN101993405B (zh) * 2009-08-27 2014-01-15 浙江华海药业股份有限公司 吲哚啉衍生物、及其制备方法和用途
CN101993406B (zh) * 2009-08-27 2014-01-15 浙江华海药业股份有限公司 光学活性的吲哚啉化合物及其制备方法
CN101993407B (zh) * 2009-08-27 2014-01-29 浙江华海药业股份有限公司 用于制备西洛多辛的吲哚啉化合物及其制备方法
CA2772997A1 (en) * 2009-09-12 2011-03-17 Sandoz Ag Process for the preparation of indoline derivatives and their intermediates thereof
CN101768056B (zh) * 2010-01-19 2013-10-16 扬子江药业集团有限公司 一种取代的苯基甲基醚的制备方法
WO2011101864A1 (en) 2010-02-17 2011-08-25 Panacea Biotec Ltd Novel process for the synthesis of phenoxyethyl derivatives
WO2011124704A1 (en) 2010-04-09 2011-10-13 Ratiopharm Gmbh Process for preparing an intermediate for silodosin
CN102311319A (zh) * 2010-07-05 2012-01-11 浙江华海药业股份有限公司 一种制备2-(2,2,2-三氟乙基)苯甲醚的方法
WO2012014186A1 (en) * 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Process for the preparation of silodosin and its novel intermediates
CN102229558B (zh) * 2010-08-05 2013-05-08 南京海纳医药科技有限公司 西洛多辛的晶型δ、它的制备方法和包含它的药物组合物
CN102229557B (zh) * 2010-08-05 2013-03-27 南京海纳医药科技有限公司 西洛多辛的半水合物晶体、制备方法和包含它的药物组合物
CZ2010837A3 (cs) * 2010-11-12 2012-03-14 Zentiva, K.S. Zpusob výroby (-)-1-(3-hydroxypropyl)-5-[(2R)-2-({2,2,2-trifluorethoxy)fenoxyethyl}amino)propyl]-2,3-dihydro-1H-indol-7-karboxamidu
WO2012062229A1 (en) 2010-11-12 2012-05-18 Zentiva, K.S. A method of manufacturing (-)-l-(3-hydroxypropyl)-5-[(2r)-2-({2,2,2-trifluoroethoxy)- phenoxyethyl}amino)propyl]-2,3-dihydro-lh-indole-7-carboxamide
CZ303060B6 (cs) * 2010-11-12 2012-03-14 Zentiva, K.S. Zpusob výroby (-)-1-(3-hydroxypropyl)-5-[(2R)-2-({2,2,2-trifluorethoxy)fenoxyethyl}amino)propyl]-2,3-dihydro-1H-indol-7-karboxamidu
WO2012131710A2 (en) 2011-03-30 2012-10-04 Panacea Biotec Ltd Novel process for the synthesis of indoline derivatives
WO2012147019A1 (en) * 2011-04-26 2012-11-01 Orchid Chemicals And Pharamceuticals Limited An improved process for the preparation of silodosin
WO2012147107A2 (en) * 2011-04-29 2012-11-01 Msn Laboratories Limited Novel & improved processes for the preparation of indoline derivatives and its pharmaceutical composition
CN102382029B (zh) * 2011-07-26 2016-06-29 浙江华海药业股份有限公司 一种西洛多辛中间体成盐制备方法
WO2013072935A2 (en) 2011-10-10 2013-05-23 Cadila Healthcare Limited Process for the preparation of silodosin
CN104302621A (zh) 2011-10-21 2015-01-21 桑多斯股份公司 制备西洛多辛的方法
CN102675182B (zh) * 2012-05-24 2014-03-26 临海天宇药业有限公司 1-(3-苯甲酰氧基丙基)-5-(2-羰基丙基)-7-腈基吲哚啉的制备方法
WO2014118606A2 (en) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited A novel process for the preparation of silodosin
CN103159664B (zh) * 2013-03-29 2016-03-23 深圳市海滨制药有限公司 一种赛洛多辛原料药及其制备方法、药物组合物
CN104140389A (zh) * 2013-05-06 2014-11-12 昆明积大制药股份有限公司 一种赛洛多辛及其中间体的制备方法
CN103420893B (zh) * 2013-08-02 2015-11-25 江苏和成新材料有限公司 制备西洛多辛中间体的方法
KR20160110517A (ko) 2014-02-06 2016-09-21 우베 고산 가부시키가이샤 인돌린 화합물의 제조 방법
KR20150098565A (ko) * 2014-02-20 2015-08-28 한미정밀화학주식회사 실로도신 제조에 사용되는 신규 중간체, 이의 제조방법 및 이를 이용한 실로도신의 제조방법
KR20150127996A (ko) * 2014-05-08 2015-11-18 한미정밀화학주식회사 실로도신 감마형 결정의 제조방법
JP6242298B2 (ja) * 2014-06-13 2017-12-06 株式会社トクヤマ １−（３−ベンゾイルオキシプロピル）−７−シアノ−５−［（２ｒ）−２−（｛２−［２−（２，２，２−トリフルオロエトキシ）フェノキシ］エチル｝アミノ）プロピル］インドリンまたはその塩を製造する方法
KR101628946B1 (ko) * 2014-07-09 2016-06-09 동방에프티엘(주) 실로도신의 개선된 제조방법
KR101725393B1 (ko) 2014-07-24 2017-04-27 주식회사 경보제약 실로도신의 제조 방법 및 신규 중간체
WO2016042441A1 (en) 2014-09-18 2016-03-24 Mankind Research Centre A novel process for the preparation of considerably pure silodosin
JP2016088847A (ja) * 2014-10-30 2016-05-23 株式会社トクヤマ （‐）‐１‐（３‐ヒドロキシプロピル）‐５‐［［（２ｒ）‐２‐（｛２‐［２‐（２，２，２‐トリフルオロエトキシ）フェノキシ］エチル｝アミノ）プロピル］‐２，３‐ジヒドロ‐１ｈ‐インドール‐７‐カルボキサミド］）の製造方法
CN104478784B (zh) * 2014-11-17 2017-02-22 武汉工程大学 一种西洛多辛草酸盐的晶型及其制备方法
KR101694262B1 (ko) * 2014-12-18 2017-01-10 (주)다산메디켐 실로도신의 결정형의 제조방법
US9356405B1 (en) 2015-03-05 2016-05-31 Sony Corporation Connector tongue element for an electrical connector plug receptacle and a method for producing the same
KR20180052728A (ko) * 2015-09-23 2018-05-18 바이오콘 리미티드 인돌린 화합물의 제조방법 및 신규한 인돌린 염
WO2017051342A1 (en) 2015-09-23 2017-03-30 Biocon Limited Crystalline forms of posaconazole intermediate and process for the preparation of amorphous posaconazole
ES2607639B1 (es) 2015-09-30 2018-02-28 Urquima, S.A Sal de ácido maleico de un intermedio de silodosina
CN106995399A (zh) * 2016-01-25 2017-08-01 北京天泰恒华医药技术有限公司 一种制备赛洛多辛的方法
KR102365411B1 (ko) * 2017-08-08 2022-02-21 (주)헥사파마텍 신규의 설폰아마이드 중간체 및 이를 사용한 실로도신의 제조방법
KR102163068B1 (ko) * 2018-07-04 2020-10-07 주식회사 가피바이오 실로도신 합성용 중간체의 제조 방법 및 이를 이용한 실로도신의 제조 방법
CN111217735B (zh) * 2018-11-27 2023-03-14 上海汇伦医药股份有限公司 赛洛多辛中间体的制备方法
WO2020237645A1 (zh) * 2019-05-31 2020-12-03 上海汇伦生命科技有限公司 赛洛多辛中间体的制备方法
CN110452149B (zh) * 2019-06-13 2021-11-02 北京鑫开元医药科技有限公司 二氢吲哚化合物的制备方法、二氢吲哚化合物及用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2104268C1 (ru) * 1991-08-02 1998-02-10 Елф Санофи Индолиновые производные, способ их получения, промежуточные соединения, фармацевтическая композиция
RU2128170C1 (ru) * 1993-02-17 1999-03-27 Чугаи Сейяку Кабусики Кайся Производные индолин-2-она и промежуточные продукты для их получения
JP2002265444A (ja) * 2001-03-08 2002-09-18 Kissei Pharmaceut Co Ltd １−（３−ベンジルオキシプロピル）−５−（２−置換プロピル）インドリン誘導体およびその使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69319551T2 (de) * 1992-12-02 1998-10-29 Kissei Pharmaceutical Indolin Verbindungen zur Behandlung von Dysurien
JP3331047B2 (ja) * 1994-06-01 2002-10-07 キッセイ薬品工業株式会社 インドリン誘導体
JP2526811B2 (ja) * 1994-07-22 1996-08-21 田辺製薬株式会社 フェネチルアミン誘導体及びその製法
SK12722000A3 (sk) * 1998-02-27 2001-03-12 Kissei Pharmaceutical Co., Ltd Deriváty indolu a farmaceutické prostriedky, ktoré ich obsahujú
JP4634560B2 (ja) * 2000-01-14 2011-02-16 キッセイ薬品工業株式会社 光学活性なインドリン誘導体の製造方法およびその製造中間体
JP2006188470A (ja) * 2005-01-07 2006-07-20 Kissei Pharmaceut Co Ltd インドリン誘導体およびその製造方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2104268C1 (ru) * 1991-08-02 1998-02-10 Елф Санофи Индолиновые производные, способ их получения, промежуточные соединения, фармацевтическая композиция
RU2128170C1 (ru) * 1993-02-17 1999-03-27 Чугаи Сейяку Кабусики Кайся Производные индолин-2-она и промежуточные продукты для их получения
JP2002265444A (ja) * 2001-03-08 2002-09-18 Kissei Pharmaceut Co Ltd １−（３−ベンジルオキシプロピル）−５−（２−置換プロピル）インドリン誘導体およびその使用方法

Also Published As

Publication number Publication date
BRPI0517515B1 (pt) 2021-03-09
CA2583660C (en) 2013-02-12
JPWO2006046499A1 (ja) 2008-05-22
KR101249865B1 (ko) 2013-04-02
EP1806340A1 (en) 2007-07-11
EP1806340A4 (en) 2009-08-12
JP5049013B2 (ja) 2012-10-17
ATE508113T1 (de) 2011-05-15
US7834193B2 (en) 2010-11-16
TWI356819B (cg-RX-API-DMAC7.html) 2012-01-21
US20070197627A1 (en) 2007-08-23
IL182642A0 (en) 2007-07-24
CA2583660A1 (en) 2006-05-04
WO2006046499A1 (ja) 2006-05-04
RU2007115888A (ru) 2008-11-10
MX2007005126A (es) 2007-07-04
ZA200703996B (en) 2008-09-25
CN101048376B (zh) 2011-03-23
HK1113364A1 (en) 2008-10-03
BRPI0517515B8 (pt) 2021-05-25
AU2005298078B2 (en) 2011-03-31
AU2005298078A1 (en) 2006-05-04
KR20070084499A (ko) 2007-08-24
EP1806340B1 (en) 2011-05-04
BRPI0517515A (pt) 2008-10-14
TW200621709A (en) 2006-07-01
ES2362788T3 (es) 2011-07-13
CN101048376A (zh) 2007-10-03
IL182642A (en) 2012-10-31
DE602005027881D1 (de) 2011-06-16

Similar Documents

Publication Publication Date Title
RU2379289C2 (ru) Соединение индолина и способ его получения
EP2970123B1 (en) Salt of omecamtiv mecarbil and process for preparing salt
WO2018233633A1 (zh) Ssao 抑制剂
JP2013532164A (ja) トロンビン特異的インヒビターを調製する方法
HUE023239T4 (en) Modulators of the prostacycline (PGI2) receptor that can be used to treat related diseases
JP2019523273A (ja) ベリノスタットの多形形態、およびその調製のためのプロセス
JP2025138626A (ja) ３－トリアゾリルメチル－１，３，５－トリアジン－２，４－ジオン化合物、およびその調製方法と応用
TW200831090A (en) Factor Xa inhibitor
CA2538315C (en) Matrix metalloproteinase inhibitors
JP4323718B2 (ja) 置換アルキルアミン又はその塩の製造方法
US20180339964A1 (en) The process of preparing indoline compounds and a novel indolinesalt
JP5305593B2 (ja) 高化学的ｒ−５−（２−（２−エトキシフェノキシエチルアミノ）プロピル）−２−メトキシベンゼンスルホンアミド塩酸塩の調製
WO2012026529A1 (ja) イソキノリン誘導体又はその塩の新規製造方法
US9169236B2 (en) Efficient process for the preparation of lapatinib and salts thereof by means of new intermediates
JP4501015B2 (ja) アミノピリミジン化合物の製造方法
CA2627724A1 (en) Process for the preparation of betamimetic benzoxazinone derivatives
JP4424728B2 (ja) 置換フェニルプロピオン酸誘導体の新規な安定結晶とその製法
KR100612779B1 (ko) 키랄 글리시딜프탈이미드를 고광학순도로 제조하는 방법
EP0658550A2 (en) Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
HK1113364B (en) Indoline compound and process for producing the same
WO2004065368A1 (ja) トランドラプリル合成中間体の製造方法
EA046640B1 (ru) Способ и промежуточное соединение для получения оксетан-2-илметанамина
BE897948A (fr) Nouveau derive du sulpiride son procede d'obtention et son utilisation therapeutique
JPH03246286A (ja) ピペラジン誘導体
NZ554718A (en) Indoline compound and process for producing the same